𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing’s sarcoma cells

✍ Scribed by Jürgen Sonnemann; Linn Dreyer; Maite Hartwig; Chithra D. Palani; Le Thi Thu Hong; Ulrike Klier; Barbara Bröker; Uwe Völker; James F. Beck


Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
409 KB
Volume
133
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Expression of an IGF-I receptor dominant
✍ Katia Scotlandi; Sofia Avnet; Stefania Benini; Maria Cristina Manara; Massimo Se 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 202 KB

IGF-IR plays an essential role in the establishment and maintenance of the transformed phenotype of ES cells and interference with the IGF-IR pathways causes reversal of the malignant potential of this neoplasm. In this report, we stably transfected a dominant negative IGF-IR expression plasmid in a

Involvement of P-glycoprotein and MRP1 i
✍ Takamitsu Okada; Kazuhiro Tanaka; Fumihiko Nakatani; Riku Sakimura; Tomoya Matsu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 399 KB

## Abstract Despite recent improvements in multimodal therapies for osteosarcoma (OS) and Ewing's family of tumors (EFTs), the prognosis of relapsed cases remains very poor because of the resistance to chemotherapy. Histone deacetylase inhibitors (HDACIs), including members of the cyclic tetrapepti

Involvement of the tumor necrosis factor
✍ Krittaya Sutheesophon; Noriko Nishimura; Yukiko Kobayashi; Yutaka Furukawa; Miki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

## Abstract Inhibition of histone deacetylase (HDAC) is a novel strategy for the treatment of leukemias via restoration of aberrantly silenced genes. In this study, we conducted a detailed analysis of anti‐leukemic effects of an HDAC inhibitor (HDI), depsipeptide (FK228), using myeloid leukemia cel